Sodium phenylacetate/sodium benzoate
(Redirected from Ammonul)
| Combination of | |
|---|---|
| Sodium phenylacetate | Antihyperammonemic |
| Sodium benzoate | Antihyperammonemic |
| Clinical data | |
| Trade names | Ammonul, Ucephan |
| AHFS/Drugs.com | Monograph |
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number | |
| UNII | |
| KEGG | |
Sodium phenylacetate/sodium benzoate, sold under the brand name Ammonul among others, is a fixed-dose combination medication used to treat high blood ammonia.[1] It is a combination of sodium phenylacetate and sodium benzoate.[1]
References
[edit]- ^ a b "Sodium Phenylacetate and Sodium Benzoate Monograph for Professionals". Drugs.com. Retrieved 16 November 2019.
 | This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it. |